Transfected Stable Cell Lines

Xpress™ Human MTAP Over-expressing Cell Line (LN18)

  • For research use only

Cat No.

ABC-X0362C

Product Type

Overexpression Stable Cell Lines

Cell Type

Glioblastoma Cell

Species

Human

Host Cell

LN18

Source Organ

Brain

Disease

Glioblastoma

Storage

Liquid Nitrogen

LN18 cells stably expressing human MTAP, useful in methylation metabolism, glioblastoma studies, and evaluating therapeutic vulnerability in MTAP deletions.

Product Image

Description

MTAP LN18 Overexpression Cell Line is a genetically engineered model derived from selected human glioblastoma (LN18) parental cell line based on customers’ requirement. MTAP LN18 overexpression cell line is generated by stable integration of exogenous human MTAP into LN18 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
The MTAP gene encodes methylthioadenosine phosphorylase, an enzyme involved in the methionine salvage pathway and purine metabolism. MTAP deletion is frequently observed in cancers such as glioblastoma, pancreatic cancer, and mesothelioma, contributing to tumorigenesis and metabolic vulnerabilities. Its overexpression allows investigation of tumor suppression and synthetic lethality pathways. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.

Species

Human

Cat.No

ABC-X0362C

Product Category

Transfected Stable Cell Lines

Size/Quantity

1 vial

Cell Type

Glioblastoma Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 °C, 5% CO2

Source Organ

Brain

Disease

Glioblastoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Overexpression Stable Cell Lines

Host Cell

LN18

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • The MTAP LN18 Overexpression Cell Line serves as a powerful tool to investigate MTAP-related metabolic regulation and drug sensitivity. This model enables mechanistic studies of purine metabolism, methylation, and targeted synthetic lethality in MTAP-deficient tumors. It is utilized for screening MTAP-replacement strategies and MTAP-co-deletion associated vulnerabilities.

Inquiring Xpress™ Human MTAP Over-expressing Cell Line (LN18)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button